Dr Joshua Howland Tamayo-sarver, MD, PH D | |
1000 W Carson St, Dept Of Emergency Medicine, Box 21, Torrance, CA 90502-2004 | |
(310) 222-3501 | |
(310) 782-1763 |
Full Name | Dr Joshua Howland Tamayo-sarver |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Location | 1000 W Carson St, Torrance, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114125796 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | A97037 (California) | Primary |
Entity Name | Cep America - California |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).
The Stanford University Program in Biodesign is partnering with the government of India to establish a new training program, called Stanford-India Biodesign, to help create the next generation of biomedical technology innovators in India.
Scientists at Brigham and Women's Hospital (BWH) have developed a scalable, next-generation platelet bioreactor to generate fully functional human platelets in vitro. The work is a major biomedical advancement that will help address blood transfusion needs worldwide.
Today's headlines include stories about the next round of health law challenges the Obama administration faces as well as the new Medicare Advantage rates scheduled to be announced today.
New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Joshua Howland Tamayo-sarver, MD, PH D 2100 Powell St, Ste 900, Emeryville, CA 94608-1844 Ph: (510) 851-7423 | Dr Joshua Howland Tamayo-sarver, MD, PH D 1000 W Carson St, Dept Of Emergency Medicine, Box 21, Torrance, CA 90502-2004 Ph: (310) 222-3501 |
News Archive
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).
The Stanford University Program in Biodesign is partnering with the government of India to establish a new training program, called Stanford-India Biodesign, to help create the next generation of biomedical technology innovators in India.
Scientists at Brigham and Women's Hospital (BWH) have developed a scalable, next-generation platelet bioreactor to generate fully functional human platelets in vitro. The work is a major biomedical advancement that will help address blood transfusion needs worldwide.
Today's headlines include stories about the next round of health law challenges the Obama administration faces as well as the new Medicare Advantage rates scheduled to be announced today.
New results presented at the 12th European Breast Cancer Conference show that a test, which looks at the activity of 70 genes in breast cancer tissue, is possible to use in the clinic to identify patients with invasive lobular carcinoma (ILC) that is at high risk of recurring and progressing.
› Verified 1 days ago
Dr. Gina L Sulmeyer, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3330 Lomita Blvd, Torrance, CA 90505 Phone: 310-517-4785 | |
Dr. Manpreet Singh, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-3501 Fax: 310-782-1763 | |
Ryan Gleber, MD, BS Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Torrance, CA 90505 Phone: 310-325-9110 | |
Dr. Daena Sarah Watcha, MD, MS Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 W Carson St, Torrance, CA 90502 Phone: 310-222-3501 Fax: 310-782-1763 | |
Mary Sun, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Dept Of Emergency Medicine, Torrance, CA 90505 Phone: 310-717-6381 | |
Robert L.r. Gibbs, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 24325 Crenshaw Blvd, # 283, Torrance, CA 90505 Phone: 424-777-6642 Fax: 877-223-4535 | |
Dr. Shannon M Stacy, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3330 Lomita Blvd, Torrance Memorial Medical Center, Torrance, CA 90505 Phone: 310-325-9110 |